Effects of kugua jiangtang capsule on blood sugar and lipid in patients with type 2 diabetes

施云星,杨延莉,黄小琴,曹尉尉,吴玲
DOI: https://doi.org/10.3321/j.issn:1673-8225.2004.27.076
2004-01-01
Abstract:BACKGROUND:The extract of Momordica charantia plant has been verified to act on reducing sugar,but it is required the further study on whether it acts on regulating lipid. OBJECTIVE:To evaluate the function of kugua jiangtang capsule(Capsule) on reducing sugar and regulating lipid in patients with type 2 diabetes. DESIGN:Controlled trial design. SETTING,PARTICIPANTS and METHODS:A total of 35 male patients with diabetes II,aged varied from 70 to 86 years,at the average of( 77± 5) years were collected in March 2003.All the patients were the retired military officers and diagnosed definitely as type 2 diabetes according to the 85' WHO Diagnosis Standard of Type 2 diabetes.All the patients had not used insulin and taken drugs for lowing sugar orally.The severe physical disorders,mental disorders,family mental disorders and severe intelligent or recognition disturbance were excluded.The Capsule prepared by the Hospital was prescribed for 35 patients.Each patients checked fasting plasma glucose(FPG),2 hours plasma glucose(PG),and blood lipid immediately before and after treating course.Blood sugar was tested by enzyme reagent method,glycosylated hemoglobin(HbA1C) by Micro Adsorption Column,total cholesterol(Tch),triglycerinum(TG) and high density lipoprotein-cholesterol(HDL-C) by enzyme reagent. MAIN OUTCOME MEASURES:Changes in blood sugar and lipid before and after medication. RESULTS:After treated with the Capsule,the results of FPG,2 hours PG and HbA1C[(5.02± 1.67) mmol/L,(9.70± 3.44)mmol/L,(5.79± 1.18)% ] were all remarkably reduced compared with the results[(7.59± 1.83) mmol/L,(12.63± 3.65)mmol/L,(6.33± 1.28)% ] before treatment( t=14.496, 8.493, 4.644, P< 0.01) . Total effective rates were 94% (33/35),80% (28/35),80% (28/35) respectively.After treatment,cholesterol and TG were remarkably reduced( t=12.400, 7.487, P < 0.01) and HDL-C remarkably increased( t=6.312, P< 0.01) .Total effective rates were 71% (25/35), 77%( 27/35), 66%( 23/35) successively. CONCLUSION:The capsule acts effectively on controlling and reducing blood sugar and lipid in type 2 diabetes.
What problem does this paper attempt to address?